I work in the Policy and Campaigns at Breast Cancer Now.
We’re currently responding to an assessment by the Scottish Medicines Consortium (SMC) for the drug trastuzumab deruxtecan (also known as Enhertu) for the treatment of HER2 positive secondary breast cancer after two or more anti-HER2 based treatments. This process will decide whether this treatment can be made available on the NHS in Scotland.
We want to hear from people with experience of this treatment to help shape what we say to the SMC about this drug. This treatment was approved by the National Institute for Health and Care Excellence (NICE) in May for use on the NHS so if you have experience of this treatment, please get in touch so we can help ensure women in Scotland can also have this as a treatment option in future.
If you would like to share your experiences with us, please get in touch through our tell us your story form by 24th August.